Bayesian approach for assessing noninferiority in a three-arm trial with binary endpoint

Author:

Ghosh Santu1,Tiwari Ram C.2,Ghosh Samiran34ORCID

Affiliation:

1. Division of Biostatistics and Data Science; DPHS, Augusta University; GA USA

2. Division of Biostatistics, CDRH; US Food and Drug Administration; Silver Spring MD USA

3. Department of Family Medicine and Public Health Sciences; Wayne State University; Detroit MI USA

4. Center of Molecular Medicine and Genetics; Wayne State University; Detroit MI USA

Funder

Patient-Centered Outcomes Research Institute

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Reference36 articles.

1. Extension of three-arm non-inferiority studies to trials with multiple new treatments;Kwong;Stat Med,2012

2. Noninferiority trials: design concepts and issues-the encounters of academic consultants in statistics;D‘Agostino;Stat Med,2003

3. FDA Non-inferiority clinical trials to establish effectivenes: Guidance for industry 2016

4. FDA Food and drug administration guidance for industry noninferiority clinical trials 2010

5. ICHE10 Ich harmonised tripartite guideline. Choice of control group and related issues in clinical trials 2009 Rockville, MD 9 13

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3